Medically-supervised hormone therapy continues to be the most effective way to boost levels of bioavailable growth hormone3. The outcome of somatropin (Nutropin AQ) on visceral adipose tissue has long been evaluated in an open-label demo of adult individuals with equally childhood-onset and Grownup-onset GH deficiency. Doses of somatropin of appro